Netoglitazone (also called MCC-555) is a hypoglycemic agent belonging to the thiazolidinedione group.[1]

Netoglitazone
Clinical data
ATC code
  • None
Identifiers
  • 5-[(6-[(2-Fluorophenyl)methoxy]naphthalen-2-yl)methyl]-1,3-thiazolidine-2,4-dione
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.233.314 Edit this at Wikidata
Chemical and physical data
FormulaC21H16FNO3S
Molar mass381.42 g·mol−1
3D model (JSmol)
  • C1=CC=C(C(=C1)COC2=CC3=C(C=C2)C=C(C=C3)CC4C(=O)NC(=O)S4)F
  • InChI=1S/C21H16FNO3S/c22-18-4-2-1-3-16(18)12-26-17-8-7-14-9-13(5-6-15(14)11-17)10-19-20(24)23-21(25)27-19/h1-9,11,19H,10,12H2,(H,23,24,25) ☒N
  • Key:PKWDZWYVIHVNKS-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References

edit
  1. ^ Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B (January 2006). "Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat". Bone. 38 (1): 74–84. doi:10.1016/j.bone.2005.07.008. PMC 1850100. PMID 16137931.